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ABSTRACT
The quest for chemicals able to operate at selected
genomic loci in a spatiotemporally controlled man-
ner is desirable to create manageable DNA dam-
ages. Mounting evidence now shows that alterna-
tive DNA structures, including G-quadruplexes and
branched DNA (or DNA junctions), might hamper
proper progression of replication fork, thus trigger-
ing DNA damages and genomic instability. Therefore,
small molecules that stabilize these DNA structures
are currently scrutinized as a promising way to create
genomic defects that cannot be dealt with properly
by cancer cells. While much emphasis has been re-
cently given to G-quadruplexes and related ligands,
we report herein on three-way DNA junctions (TWJ)
and related ligands. We first highlight the biological
implications of TWJ and their strategic relevance as
triggers for replicative stress. Then, we describe a
new in vitro high-throughput screening assay, TWJ-
Screen, which allows for identifying TWJ ligands with
both high affinity and selectivity for TWJ over other
DNA structures (duplexes and quadruplexes), in a
convenient and unbiased manner as demonstrated
by the screening of a library of 25 compounds from
different chemical families. TWJ-Screen thus repre-
sents a reliable mean to uncover molecular tools able
to foster replicative stress through an innovative ap-
proach, thus providing new strategic opportunities
to combat cancers.
INTRODUCTION
Replicative stress is a generic term that encompasses all pu-
tative impediments to DNA replication able to stall or col-
lapse replication fork. It thus creates DNA damages that
trigger unsustainable genetic instabilities, which eventually
leads to cell death. (1) Novel chemotherapeutic interven-
tions aim at bolstering this stress as away to inflict severe ge-
netic injuries to cancer cells to cause proliferation machin-
ery stoppages. (1,2) DNA-damaging drugs, including oxi-
dizing and alkylating agents as well as inhibitors of DNA-
related enzymes that trap ternary drug/DNA/protein com-
plexes, represent a golden way to provoke replicative stress.
(3–7) An alternative way is to consider non-canonical DNA
structures that arise from repetitive genomic sequences:
they represent another class of topological hindrances to
replication fork progression that equally threaten genetic in-
tegrity. (8,9) The nature of the non-canonical DNA struc-
tures is dictated by the repetitive sequences involved: di-
rect tandem repeats can fold into G-quadruplexes if the
sequence is guanine-rich or into left-handed Z-DNA if
the sequence comprises regularly alternating purines and
pyrimidines, while inverted repeats can adopt junction-like
structures, known as slipped-stranded (three-way junction,
TWJ) or cruciform (four-way junction) structures. (10) In-
terestingly, DNA replication favors non-canonical DNA
structures both upstream and downstream the replication
fork due to positive and negativeDNA supercoiling, respec-
tively, along with strand separation.
Quadruplexes have been the focus of the greatest inter-
est over the past years as genetic levers involved in DNA
transactions such as replication (with both activating and
inhibiting outcomes as replication fork barriers or triggers
for replication origins, respectively) (11–16) and gene ex-
pression (at both transcriptional and translational levels,
for DNA and RNA quadruplexes, respectively). (17–19)
The identification of quadruplex-specific small molecules
(termed quadruplex ligands) (20,21) able to chemically op-
erate these genetic levers has kept the limelight away from
other higher-order DNA structures, although they are at
least as interesting. Here, we decided to focus on TWJ
with the aim of implementing a reliable high-throughput
screening (HTS) assay to identify valuable TWJ ligands.We
developed an experimental setup that is both robust and
practically convenient, as demonstrated by the screening of
a library of 25 compounds belonging to different chemi-
cal families to bring out the most promising candidates,
which must display high affinity and selectivity for TWJ
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over other DNA structures (here duplexes and quadru-
plexes). This assay, named TWJ-Screen, was built on the ba-
sis of literature precedents to circumvent experimental pit-
falls usually associated with ligand/DNA assays. The de-
velopment of such in vitro testing was spurred on by the
discovery that DNA quadruplexes might represent valuable
anticancer targets. To identify promising drug candidates,
numerous techniques have been adapted to or created for
the study of quadruplexes, (22,23) relying on ultraviolet–
visible absorption (UV–Vis) and circular dichroism (CD)
spectroscopies, (24) isothermal (ITC) and differential scan-
ning (DSC) calorimetries, (25,26) as well as mass spectrom-
etry (ESI-MS), (27) crystallography (28) and both nuclear
magnetic (NMR) (29,30) and surface plasmon (SPR) (31)
resonance techniques. However, among the most sensitive
assays developed so far, fluorescence-based methodologies
rank high. Fluorescence spectroscopy indeed offers many
advantages, including high sensitivity (it requires low con-
centrations of both ligand and DNA and allows for moni-
toring subtle molecular changes) and practical convenience
(fluorescence readers, wide arrays of dyes and fluorescently
labeled oligonucleotides are now commercially available).
Three main fluorescence-based approaches have been de-
veloped so far, relying either on the fluorescence of the
ligand per se (i.e. equilibrium dialysis) (32,33) or on flu-
orescently labeled DNA, in a covalent (i.e. fluorescence
resonance energy transfer (FRET)-melting assay) (34,35)
or non-covalent manner (i.e. G4-FID assay).(36–38) Each
of these techniques suffers from technical limitations: for
instance, the equilibrium dialysis assay is reliant on the
spectroscopic properties of the ligand itself, the FRET-
melting protocol on covalent DNA labeling that might have
both steric and electronic consequences on the ligand/DNA
binding, and the G4-FID experiment on the addition of
dyes to be displaced (thiazole orange (TO), TO-PRO3)
whose binding site might be uncertain. Conversely, each of
these techniques has its own advantages: for instance, the
equilibrium dialysis assay uniquely offers an unbiased read-
ing of the sequence and structural selectivity of a given can-
didate, the FRET-melting protocol is easily implementable
as an HTS assay that allows for assessing concomitantly
the quadruplex affinity and selectivity of series of ligands,
and the G4-FID experiment is performed as an HTS assay
with unmodified oligonucleotides in isothermal conditions.
TWJ-Screen was thus devised with these limitations and ad-
vantages in mind, and also in light of the insights gained
during previous TWJ-based studies, since some assays have
already been transposed to the study of TWJ and the iden-
tification of promising TWJ ligands. Hannon and cowork-
ers have pioneered this field through the studies of dimetal-
lic supramolecular cylinder derivatives assessed via a panel
of techniques including X-ray analysis, (39,40) NMR, (41)
polyacrylamide gel electrophoresis (PAGE) (42) and both
in vitro and in cellulo FID assays (with ethidium bromide
and Hoechst 33258, respectively). (43,44) Subsequently, we
have investigated TWJ/ligand interactions by UV-melting
and PAGE, (45,46) along with an HTS FRET-melting as-
say enabling an easy quantification of the differential affin-
ity of small molecules for a panel of alternative DNA struc-
tures via the BONDS (branched and other non-canonical
DNA selectivity) index. (47) More recently, Chenoweth et
al. have also developed a panel of in vitro techniques, in-
cluding UV-melting, CD-melting and isothermal FRET as-
says to assess the TWJ-interacting properties of triptycene
derivatives. (48,49) Altogether, these studies have laid solid
foundations for ongoing works but have been restricted to
few families of compounds only. To expand the portfolio
of promising TWJ ligands, we devised the HTS assay TWJ-
Screen, whose principle is schematically represented in Fig-
ure 1.
The design of TWJ-Screen was established in light of
our recent investigations on cationic azacryptands as TWJ
ligands, whose TWJ-interacting properties were assessed
through a panel of in vitro techniques including FRET-
melting and PAGE. (45) These two assays are complemen-
tary in that the former monitors the ability of ligands to
increase the thermal stability of folded TWJ while the latter
their capability to shift the equilibrium between the three
separated strands and the liganded, folded TWJ. Thus, the
ligand does not promote the TWJ folding itself but binds
its folded conformation, thereby shifting the equilibrium to-
ward the folded TWJ according to the Le Chatelier’s princi-
ple. The degree of ligand-induced increase of the fraction of
the folded TWJ is thus directly related to its binding affinity.
Interestingly, a first screen of the anti-proliferative proper-
ties of azacryptands against melanoma cells (B16F10) high-
lights a particular relationship between cellular and TWJ-
entrapping activities.We therefore decided to develop TWJ-
Screen (Figure 1) for identifyingmolecules able to efficiently
trap folded TWJ in a HTS manner: contrarily to FRET
and PAGE assays, which suffer from practical aforemen-
tioned drawbacks (a temperature-variable protocol for the
former, a low throughput and poorly reproducible proto-
col for the latter), TWJ-Screen has been designed to (i) be
isothermal, meaning that it is performed at room temper-
ature, alleviating the need of variable temperature fluores-
cence microplate reader such as, quantitative polymerase
chain reaction (qPCR) apparatus routinely implemented
for FRET-melting assays for instance (34,47) and is ap-
plicable to small-molecules known to be thermosensitive;
(ii) involve fluorescently labeled oligonucleotides (for sen-
sitivity concerns), making it implementable as HTS assay
in 96-well plates, with a particular care taken in the intro-
duction of the FRET pair labels (i.e. fluorescein amidite
(FAM) and carboxytetramethylrhodamine (TAMRA)) as
far as possible from the putative ligand binding sites in
TWJ to not disturb binding events; (iii) be versatile since
the use of labeled DNA opens also the possibility of adding
unlabeled oligonucleotides in the mixture (e.g. duplexes,
quadruplexes) to perform this assay in a competitive man-
ner, thus allowing for the evaluation of both TWJ affinity
and selectivity of candidates in a single experiment; and (iv)
comprise a series of control experiments that are performed
in a concomitant manner, which allows for discarding false
negatives and positives, the latter being mainly due to ill-
defined interactionswith fluorophores (i.e. FAM).We there-
fore report herein on the implementation of TWJ-Screen
along with the assessment of its reliability through the un-
biased screening of a library of 25 compounds belonging to
different chemical families.
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Figure 1. (A) Schematic representation of the TWJ-Screen assay. (B) Representative examples of fluorescence spectra recorded during the assay (1 M
DNA, 5 M ligand in 10 mM lithium cacodylate buffer (pH 7.2) + 10 mMKCl/90 mM LiCl, λex = 492 nm, λem = 505–675 nm). (C) Schematic represen-
tation of the 96-well plate organization of the TWJ Screen assay (basic mode, dose-response and competitive experiments).
MATERIALS AND METHODS
Nucleic acids and buffer
All oligonucleotides are purchased from Eurogentec
(Seraing, Belgium) in OligoGold® purity grade and
purified by RP-high pressure (or high performance) liquid
chromatography (RP-HPLC) at ∼200 nmol scale for ds26
and at ∼1000 nmol for all other oligonucleotides. TWJ-
forming sequences: the lyophilized strands are first diluted
in deionized water (18.2M.cm resistivity) at 500 M. The
precise concentration of these stock solutions is determined
after a dilution to 2 M theoretical concentration (i.e. 4 l
in 996 l water, as triplicate) via UV–Vis spectra analysis
at 260 nm (after 5 min at 90◦C), using the molar extinction
coefficient values provided by the manufacturer. These
solutions are subsequently diluted at 25 M concentration
in a CacoK buffer (comprised of 10 mM lithium cacodylate
buffer (pH 7.2) plus 10 mM KCl/90 mM LiCl) prior to
use, without any further preparation. Competitors: the
lyophilized ds26 and TG5T constitutive strands are firstly
diluted in deionized water (18.2 M.cm resistivity) at
500 M (ds26) or 1000 M (TG5T). The duplex ds26 is
prepared by mixing 80 l of the stock solution (500 M)
with 16 l of a lithium cacodylate buffer solution (100 mM,
pH 7.2), plus 16 l of a KCl/LiCl solution (100/900 mM)
and 48 l of water. The quadruplex TG5T is prepared by
mixing 80 l of the stock solution (1000 M) with 32 l
of a lithium cacodylate buffer solution (100 mM, pH 7.2),
plus 32 l of a KCl/LiCl solution (100/900 mM) and 96
l of water. The high-order structures, that is duplex (ds26)
and quadruplex (TG5T) are folded as follows: the solutions
are heated at 90◦C for 5 min, cooled at 65◦C for 1 h, 55◦C
for 1 h, 50◦C for 1 h, 45◦C for 1 h, 40◦C for 30 min, 35◦C
for 30 min, 30◦C for 30 min, 25◦C for 1 h and then stored at
least overnight at 4◦C. The precise concentration of these
solutions is determined after a dilution to 2 M theoretical
concentration (i.e. 4 l in 996 l water, as triplicates) via
UV–Vis spectra analysis at 260 nm (after 5 min at 90◦C).
Panel of ligands
Ligands used in the TWJ-Screen protocol have been pre-
pared as described elsewhere (except for TMPyP4, which is
commercially available): the cyclo-tris-intercalators (CTIs);
(45) the cyclo-bis-intercalators (CBIs) (50) except 9,10-
BisAN-O, (51) 2,6-BisNP-O, (52) and 2,6-BisNP-NH2 &
2,6-BisNP-2PY; (53) the organometallic cages, including
the rectangles, (54) the prisms (55,56) and the cubes;
(57,58) and the control compounds TACN-Q (46) and
PNADOTASQ. (59) Stock solutions are first prepared as 1
mM dimethyl sulfoxide (DMSO) solutions, subsequently
diluted at 100 M solutions in water prior to use.
Experimental protocol of TWJ-Screen
Experiments are performed in a 96-well format using either
anAgilent StratageneMx3005P or a BMGLabtechCLAR-
IOStar machine equipped with FAM filters (λex = 492 nm;
λem = 516 nm) at 25◦C. TWJ-Screen experiments are imple-
mented (Figure 1):
i) in buffered solution, here a buffer named ‘CacoK’made
of 10 mM lithium cacodylate buffer, pH 7.2, supple-
mented with 10mMKCl/90mMLiCl to reach 110mM
final ionic strength. The total volume per well is 100 l.
ii) with the labeled DNA sequences FAM-TWJ-
S1: FAM-d[5
′
CG2A2CG2CACTCG3
′
], TWJ-S2:
d[5
′
CGAGTGCAGCGTG23
′
] and TWJ-S3-TAMRA:
d[5
′
C2ACGCTCGT2C2G3
′
]-TAMRA. Each of the
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strand is added in a step-wise manner (FAM-TWJ-S1
first, then TWJ-S2 and finally TWJ-S3-TAMRA, 0.8
l of a 25 M solution); the final concentration of
DNA per well is 0.2 M.
iii) with 0.2 M DNA in absence or presence of 5 molar
equivalents (mol. equiv.), that is, 1.0 M ligand.
iv) as triplicates, with six control wells per plate: three wells
with FAM-TWJ-S1 alone (0.8 l of a 25 M solution)
and three wells with the three separated strands, a mix-
ture termed  M  (FAM-TWJ-S1 first, then TWJ-
S2 and finally TWJ-S3-TAMRA, 0.8 l of a 25 M
solution), along with six wells per ligand: three wells
with FAM-TWJ-S1 (0.8 l of a 25 M solution) + 1
M ligand (1 l of a 100 M solution, 5 mol. equiv.)
and three wells with themixtureM (FAM-TWJ-S1 first,
then TWJ-S2 and finally TWJ-S3-TAMRA, 0.8 l of a
25 M solution) + 1 M ligand (1 l of a 100 M so-
lution, 5 mol. equiv.).
v) with 1 h incubation at 25◦C. After preparation, the mi-
croplate is centrifuged for 30 s, then gently stirred for
1 h and centrifuged again for 30 s before fluorescence
reading.
Additional TWJ-Screen experiments can be performed
concomitantly to address specific issues or meet specific
needs (Figure 1), including:
i) time course measurements (the fluorescence of each
well ismeasured every 1 h (for 18 h-experiment) at 25◦C)
and dose-response experiments (the ligand is added at
1, 2 and 5 M (1, 2 and 5 l of a 100 M solution, 5,
10 and 25 mol. equiv., respectively)).
ii) additional controls performed with mixtures  M’ 
(in which TWJ-S2 is missing, to demonstrate that the
lack of one constitutive strand impedes ligand binding
to TWJ) or  M”  (in which an unlabeled TWJ-
S3 is used, to investigate the nature of the fluorescence
quench that results from the FAM/TAMRA proxim-
ity).
iii) competitive experiments performed with the mixture
M (FAM-TWJ-S1 first, then TWJ-S2 and finally TWJ-
S3-TAMRA, 0.8 l of a 25 M solution), without or
with subsequent addition of 1 M ligand (1 l of a 100
M solution, 5 mol. equiv.), without or with increasing
amounts (2 or 5 M, 10 or 25 mol. equiv.) of unlabeled
competitors (either the duplex ds26 or the quadruplex
TG5T).
Final data are analyzed by using Excel and OriginPro8.
The emission of FAM is normalized at 100% (using thewells
containing FAM-TWJ-S1 only) and results are expressed as
normalized fluorescence intensity (NFI) values.
RESULTS
The TWJ-Screen protocol was designed so as to avoid pit-
falls frequently encountered in the development of in vitro
fluorescence assays. As detailed in the ‘Materials andMeth-
ods’ section, a particular attention has been paid to every
experimental parameter including the choice of the buffer
(CacoK is known to be spectroscopically inert) and of its
salt content (110 mM ionic strength, to be closed to phys-
iologic salt conditions), the choice of the studied DNA se-
quences (TWJ-S1, -S2 and -S3 were initially used by Brabec
and coworkers, (42) since they fold into a TWJ structure
comprising three 7-bp arms) and the position of the fluo-
rophores (located in close proximity to each other at the
end of a duplex arm of the folded TWJ, that is, far from
the central TWJ cavity, Figure 1). Also, low concentrations
of both DNA (0.2 M) and ligand (1.0 M) were em-
ployed to be commercially attractive (with regard to the
cost of labeled oligonucleotides) and convenient (due to the
sometimes-difficult access to chemicals), and also because
these experimental conditions afford good signal-to-noise
ratios along with dilution conditions in which the three sep-
arated strands do not associate spontaneously. Importantly,
the protocol allows for reaching high levels of confidence
due to the numerous control experiments performed both
without ligand (with FAM-TWJ-S1 alone for providing the
reference 100% FAM fluorescence, with the mixture of the
three strands for monitoring the lack of spontaneous TWJ
folding) and in the presence of the ligand (with FAM-TWJ-
S1 + 1 M ligand for insuring that the FAM fluorescence is
not affected by the presence of the ligand, with the mixture
of the three strands + 1M ligand for monitoring the TWJ-
binding activity of the ligand per se). Finally, this protocol
is practically convenient (over 1 h at 25◦C, which is suited
for evaluating the TWJ-binding activity of ligands while
not long enough for spontaneous TWJ folding) and ver-
satile, affording the possibilities of conducting time course
measurements (over 18 h for instance), dose-response (with
ligand concentration up to 5 M for instance) and even
competitive experiments (in presence of unlabeled duplex
or quadruplex for instance).
A representative panel of 25 candidates
To assess whether TWJ-Screen is relevant for the detection
of promising TWJ ligands, we have implemented this assay
with a representative panel of 25 different candidates be-
longing to different families of compounds (Figure 2):
i) three azacryptands from the CTI (macrobicyclic) series,
including 2,7-TrisNP, 2,8-TripsPZ and 3,3′-TrisBP: (60)
the TWJ-interacting properties of these three ligands
have already been assessed through FRET and PAGE
techniques; (45)
ii) eleven azacryptands from the CBI series, including 2,7-
BisA-O, 2,7-BisNP-O, 2,6-BisNP-O, 2,7-BisNP-N, 2,6-
BisNP-NH2, 9,10-BisAN-O, 4,5-BisA-O, 2,6-BisNP-
2PY, 4,7-BisPN-O, 4,4′-BisBPy-O and 1,5-BisNP-O:
(50–53,60) these ligands are related toCTI but are struc-
turally simpler, being comprised of a single macrocyclic
system only;
iii) eight water-soluble organometallic cages, (54–58,61)
belonging to three different families of supramolecu-
lar ruthenium complexes, that is, two supramolecular
rectangles (Rec-DONQ and Rec-DOBQ), two prisms
(Prism-DONQ and Prism-DOBQ) and four cubes
(Cube-Ni-DOBQ, Cube-Zn-DOBQ, Cube-DOBQ and
Cube-DONQ): these candidates have been selected
since they are known to be thermosensitive (therefore
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Figure 2. Structures of the 25 candidates whose TWJ-interacting properties were evaluated via TWJ-Screen.
being non-suited to FRET-melting analysis) and they
display defined shapes and volumes that could be valu-
able for interacting with the TWJ-binding site (i.e. the
branch point, vide infra);
iv) and finally, three control compounds: TACN-Q, a tri-
aza-cyclononane derivative already thoroughly inves-
tigated for its TWJ-interacting properties; (45,46) the
porphyrin TMPyP4 as a model of DNA binder with-
out selectivity for any secondary structure; (47) and
PNADOTASQ, a biomimetic quadruplex ligand with
exquisite selectivity for quadruplexes. (59,62–63)
These candidates have been selected since their shapes
might be suited to fit within the TWJ ligand binding site,
that is, the branch point. Indeed, TWJ present two distin-
guishing structural features, three grooves (the duplex arms)
and a central cavity (the branch point) that results from
the convergence of three duplex arms. To be considered
as a promising TWJ ligand, a molecule must interact only
with the structural peculiarity of TWJ, the branch point
(schematically represented in Figure 1), which differs from
classical nucleic acid binding sites primarily grooves and
base pair-, triad- and tetrad-stacking for duplexes, triplexes
and quadruplexes, respectively. Invaluable structural in-
sights have been gained through X-ray crystallographic
analyses: (39,64) this cavity is a prism-like space whose side-
walls are made of base-pairs, suited to accommodate steri-
cally demanding ligands like M. J. Hannon’s supramolec-
ular cylinders for instance. Therefore, an exquisite shape
complementarity along with stacking interactions between
the branch point (host) and a ligand (guest) might offer
an efficient way to bind to folded TWJ from a mixture of
three separated strands. Also, it might provide TWJ selec-
tivity since the branch point of other nucleic acid junctions,
chiefly four-way DNA junctions (such as the Holliday junc-
tion), (65) differs in shapes and dimension.
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The implementation of TWJ-Screen with 25 candidates: a
comparative study
The first series of investigations was performed to assess the
TWJ-interacting properties of the 25 selected ligands. Re-
sults seen in Figure 3 are to be interpreted as follows:
i) the normalized FAM fluorescence intensity (NFI)
of two control mixtures, i.e. FAM-TWJ-S1 alone
(gray bars) and FAM-TWJ-S1 + TWJ-S2 + TWJ-S3-
TAMRA (black bras) should be equal, to demonstrate
that the mixture of the three separated strands does not
provide folded TWJ structure under these experimental
conditions;
ii) the FAM fluorescence intensity of the third control ex-
periments, i.e. the mixture of FAM-TWJ-S1 + 5 mol.
equiv. ligand (orange bars), should be the closest pos-
sible to the two other controls, to demonstrate that the
FAMfluorescence is minimally affected by the presence
of the ligand or better, that the ligand interacts only
marginally with the fluorophore;
iii) and finally, the FAM fluorescence intensity of the mix-
ture of the three strands FAM-TWJ-S1, TWJ-S2 and
TWJ-S3-TAMRA + 5 mol. equiv. ligand should be the
smallest possible (brown bars), to illustrate the ligand
binding to the folded TWJ, illustrated here by the spa-
tial proximity between the FAM on the S1 strand and
the TAMRA on the S3 strand.
To summarize, this assay allows for a convenient visual-
ization of the specific TWJ-binding activity of candidates,
since a candidate is promising only if a/ the FAM fluores-
cence intensities of the three control experiments are equal
(gray, black and orange bars), while b/ that of the mixture
of separated strands in presence of the ligand is the lowest
possible (brown bars). As seen in Figure 3, the assessment
of the 25 selected candidates provides a variety of represen-
tative scenarios:
i) first, the protocol is suited to the intended use of the
assay since the three strands do not fold spontaneously
in TWJ structure in the selected conditions (as demon-
strated by the grey and black bars, both standing in the
same NFI range, 100 and 99%, respectively).
ii) some ligands do not interact with TWJ strands, il-
lustrated by the NFI (including standard deviation)
of all mixtures is >80%, i.e. the CBIs 2,7-BisNP-O,
2,6-BisNP-2PY, 4,4′-BisBPy-O and the supramolecular
rectangles Rec-DONQ and Rec-DOBQ (gray arrows);
iii) some ligands can be considered as false positives, since
they lead to a strong decrease of the fluorescence of the
mixture of separated strands + ligand (brown bars) as
compared to gray bars, but in a way disconnected from
their TWJ-entrapping activity. This originates in their
strong interaction with FAM, as demonstrated by the
comparison between orange and brown bars, with a flu-
orescence of the FAM-TWJ-S1 + ligand mixture (or-
ange bars) that is either roughly equal (TMPyP4 (17 and
19%), 2,6-BisNP-O (59 and 59%), 2,6-BisNP-NH2 (72
and 70%), 4,7-BisPN-O (57 and 48%), Prism-DONQ
(13 and 14%), Cube-Zn-DOBQ (14 and 14%), Cube-
DOBQ (15 and 16%), Cube-DONQ (12 and 15%) and
to a lesser extent, PNADOTASQ (owing to the impor-
tant SD), or even smaller (2,8-TrisPZ (60 and 67%), 2,7-
BisA-O (10 and 15%), 4,5-BisA-O (33 and 47%), 2,7-
BisNP-N (26 and 51%), Prism-DOBQ (14 and 22%),
Cube-Ni-DOBQ (14 and 24%)) than that of the mix-
ture of all strands in the presence of the ligand (brown
bars). These candidates are thus discarded for further
investigations (vide infra);
iv) and finally, some ligands are promising candidates,
which can be classified in two categories, a/ the fair
ligands, which interfere somehow with the FAM flu-
orescence (orange bars) but bind to folded TWJ to a
greater extent (brown bars), including the CTIs 2,7-
TrisNP (34 and 23%) and 3,3′-TrisBP (30 and 19%), and
b/ the good ligands, which minimally affects the flu-
orescence of FAM-TWJ-S1 alone but efficiently bind
to folded TWJ: these examples, which comprise the
CBIs 9,10-BisAN-O (77 and 37%) and 1,5-BisNP-O
(101 and 60%) along with, to a lesser extent, TACN-
Q (102 and 72%), are consequently the most promis-
ing TWJ-binders from this panel of candidates (orange
stars, Figure 3).
Control experiments to further assess the relevance of the
TWJ-Screen protocol
This first series of results is promising but several technical
parameters of the protocol must be checked to further as-
sess the validity of this assay. To this end, we performed a
series of control experiments with the best identified ligand,
i.e. the 9,10-BisAN-O (Figure 4):
i) first, the incubation time: the TWJ-Screen protocol has
been designed to be practically convenient, particularly
regarding its timeframe, that is, 1 h incubation at 25◦C
of all mixtures before fluorescence reading. However,
we wonder whether the time would impact TWJ-Screen
results and consequently performed time course mea-
surements.Microplate analyses were carried out 15min,
1, 2 or 18 h after sample preparation. As seen in Fig-
ure 4, the incubation time does not drastically influ-
ence the TWJ-binding activity of 9,10-BisAN-O (with
NFI between 37 and 49%, brown bars) but longer times
should be avoided since they favor the random associ-
ation of ligand/FAM-TWJ-S1 (with NFI from 93 to
58%, orange bars). Interestingly, spontaneous, that is,
non-ligand-assisted TWJ folding does not occur even
after 18 h incubation (black bars). This control allows
for the selection of the practically convenient 1h incu-
bation in the optimized TWJ-Screen protocol;
ii) second, the ligand concentration: FRET-based assays
are usually carried out with an excess of ligand (1M, 5
mol. equiv.) with respect to the labeled oligonucleotides
(0.2 M). We, thus wondered whether the ligand:DNA
ratio could influence their TWJ-binding activity, privi-
leging higher ratios owing to the improvable results ob-
tained with 9,10-BisAN-O at 1 M concentration. Ex-
periments were thus performed with 1, 2 and 5 M of
9,10-BisAN-O (5:1, 10:1 and 25:1 ratio, respectively).
Results seen in Figure 4 highlight that TWJ binding oc-
curs in a dose-response manner, but to a limited extent
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Figure 3. TWJ-Screen results obtained with the 25 candidates: NFI for FAM-TWJ-S1 alone (gray bars), the mixture of the three strands (FAM-TWJ-S1
+ TWJ-S2 + TWJ-S3-TAMRA=M, black bars), FAM-TWJ-S1 in presence of 5 mol. equiv. ligand (FAM-TWJ-S1 + ligand, orange bars) and the mixture
of the three strands in presence of 5 mol. equiv. ligand (M + ligand, brown bars). Gray arrows indicate compounds that do not interact with DNA; orange
arrows highlight the best difference between the control and the correct TWJ binding experiments; orange stars indicate the most promising ligands.
Figure 4. Control TWJ-Screen experiments carried out with 9,10-BisAN-O and mixtures of TWJ strands (FAM-TWJ-S1, TWJ-S2 and TWJ-S3-TAMRA,
plain bars), without TWJ-S2 (horizontally hatched bars) or with TAMRA-free TWJ-S3 (cross-hatched bars), performed as a function of the ligand con-
centration (1–5 M, vertically hatched bars) and time (15 min to 18 h).
since NFI decrease from 49 to 42% only (brown, verti-
cally hatched bars). This control allows for the selection
of the routine 1 M ligand concentration in the opti-
mized TWJ-Screen protocol;
iii) finally, using unlabeled strands to ascertain the origin
of the fluorescence quench: we first performed an ex-
periment in which TWJ-S2 is missing to both assess
whether the lack of one constitutive strand of TWJ
impedes its ligand-stabilized folding and illustrate that
FAM quenching indeed originates in proper TWJ for-
mation. Results seen in Figure 4 (gray, horizontally
hatched bars) confirm these two assumptions since the
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ligand-free DNA mixtures provides comparable NFI
(82 versus 84% for mixtures with and without TWJ-S2,
respectively), while the lack of TWJ-S2 is detrimental to
the ligand-promoted TWJ structures (37 versus 71% for
mixtures with and without TWJ-S2, respectively). This
was further demonstrated using TMPyP4 as a control
ligand: as seen in Figure 3, this molecule quenches ef-
ficiently FAM fluorescence regardless of the mixtures
it is involved in; this is further substantiated here, with
NFI between 17 and 19% (diagonally hatched bars)
when TMPyP4 interacts with DNA mixtures compris-
ing one, two or three constitutive TWJ strands (or-
ange, brown and pale yellow bars, respectively). This
series of results clearly demonstrates the FAM quench
monitored (i) with the false positives is indeed caused
by FAM interaction only; and (ii) with the promis-
ing ligands actually originates in stabilized folded TWJ.
We finally performed an experiment in which TWJ-S3
is used unlabeled, to assess whether the fluorescence
quench observed with the best candidates is due to
strand hybridization (i.e. FAM/nucleobases proximity)
or FRET effect (i.e. FAM/TAMRA proximity). The
lack of quenching in mixtures comprising TAMRA-
free TWJ-S3 strand (gray, cross-hatched bars) confirms
that TAMRA quencher is mandatory, and thus, that a
FRET phenomenon takes place in our conditions, al-
though the exact nature of this fluorescence quench-
ing remains uncertain since even with the established
FAM/TAMRA FRET-pair, two modes of quenching
are possible, i.e. the FRETmode and the contact mode.
(66,67) As further detailed in the Discussion, both con-
tributions (which mostly depend on the distance be-
tween the two fluorophores) can take place concomi-
tantly and are difficult to disentangle.
Altogether, this series of control experiments further sup-
ports the reliability of the design of the TWJ-Screen assay,
which thus allows for readily discriminating small molecule
candidates on the basis of their TWJ-entrapping activity.
Confirmation of the TWJ interacting properties: a competi-
tive study
We next performed competitive experiments to assess the
TWJpromoting capabilities of identified ligands in presence
of an excess (10 and 25 mol. equiv.) of unlabeled oligonu-
cleotides of different structures, here, the duplex ds26 and
the quadruplex TG5T, which are two competitors rou-
tinely used for FRET-melting investigations. The presence
of competitive nucleic acids requires additional controls to
confirm the lack of influence of the unlabeled competitors
on the TWJ system: to this end, additional wells contain-
ing either FAM-TWJ-S1 or the mixture of all strands in
the presence of 25 mol. equiv. of competitors were added as
controls (hatched bars, Figure 5). This new series of exper-
iments was performed with the two most promising TWJ-
binders, i.e. the CBIs 9,10-BisAN-O and 1,5-BisNP-O: re-
sults seen in Figure 5 (the plain bars correspond to the ex-
periments described above, the cross-hatched and diagonal
hatched bars for experiments performed in presence of ds26
and TG5T, respectively) first confirm the suitability of this
competitive assay since the FAMfluorescence of all controls
stands in the same NFI range, i.e. between 97 and 114%.
This confirms that the excess of competitor does not impact
the fluorescence of the TWJ system. More importantly, this
assay enlightens that the two ligands still efficiently bind to
folded TWJ in a competitive context: indeed, the NFI ob-
tained with 9,10-BisAN-O and 1,5-BisNP-O are marginally
affected by the presence of increasing amounts (0, 10 and 25
mol. equiv.) of either ds26 (NFI = 60–58% and 71–60% for
9,10-BisAN-O and 1,5-BisNP-O respectively, red and blue
bars, respectively) or TG5T (NFI = 39–42% and 61–50%
for 9,10-BisAN-O and 1,5-BisNP-O, respectively).
Collectively, this series of experiments and results validate
the efficiency of TWJ-Screen for finding promising TWJ
ligands, i.e. compounds capable of selectively binding to
folded TWJ even in a competitive context. This assay allows
for identifying two small molecules, 9,10-BisAN-O and 1,5-
BisNP-O, already studied for their quadruplex interacting
properties (quantified as low to inexistent for 9,10-BisAN-
O and 1,5-BisNP-O, respectively) (60) as valuable TWJ lig-
ands. Of note, we further studied the TWJ interactions of
these two promising ligands via alternative and commen-
tary techniques, i.e. PAGE and competitive FRET-melting
assays: the collected results seen as Supplementary Data
confirm both their efficient binding to folded TWJ from
strand mixtures (Figure S1) and their capability to ther-
mally stabilize pre-folded TWJ (Supplementary Figure S2
and Table S1). We are now investigating their ability to trig-
ger replicative stress, create DNA damages and provoke cell
proliferation stoppages; results obtained so far––which are
beyond the scope of this Method article––are compelling
in that they show that both 9,10-BisAN-O and 1,5-BisNP-
O do damage DNA (immunodetection and western blot
analyses) and arrest cancer cell growth (anti-proliferative
assays). These results (to be reported elsewhere) thus give
strong credit to a broader search for chemicals able to pro-
mote and/or stabilize TWJ, and cast a bright light on the
user-friendly TWJ-Screen assay that will undoubtedly con-
tribute to this quest in a significant manner.
DISCUSSION
Triggering DNA damages via replicative stress is a relevant
anticancer strategy owing to the propensity of rapidly divid-
ing cells to accumulate replicative lesions. In this context,
the quest of chemicals promoting roadblocks that might
hamper the proper progression of the replication fork opens
new therapeutic opportunities. Here, we report on the de-
velopment of an in vitroHTS assay that represents the very
first step of this quest. Indeed, for cell-based investigations
to be reliably performed and interpreted, accurate and spe-
cific molecular tools must be uncovered that display both
exquisite affinity and selectivity for their DNA targets. Be-
sides the rational design of TWJ interacting compounds (i.e.
the design of molecules with volumes and shapes suited to
fit into the branch point of the TWJ), efficient but offer-
ing a limited diversity of ligands, high-throughput screens
of unbiased chemical libraries provide unique opportuni-
ties to discover unexpected chemical scaffolds. We, thus in-
vested massive efforts in the development of an HTS assay
on the basis of what has been done and reported over the
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Figure 5. Competitive TWJ-Screen results obtained with 9,10-BisAN-O (orange and red bars) and 1,5-BisNP-O (orange and blue bars) for experiments
performed with mixtures of TWJ forming sequences (FAM-TWJ-S1, TWJ-S2 and TWJ-S3-TAMRA) in absence (plain bars) or presence of an excess (10
and 25 mol. equiv.) of competitor, either the duplex-DNA ds26 (cross-hatched bars) or the quadruplex-DNA TG5T (hatched bars).
past years in various nucleic acids fields, which allows for
the identification of TWJ interacting agents on highly strin-
gent criteria in terms of efficiency and selectivity. This assay
named TWJ-Screen provides information about the capac-
ity of a ligand to interact with TWJ that folds from sepa-
rated DNA single strands (to mimic DNA strand separa-
tion that occurs during replication) in a competitive con-
text (that is, in presence of mixture of nucleic acids). This
was made possible by the use of fluorescently labeled DNA
(one strandwith FAM, the other onewith TAMRA) that al-
lows for monitoring the TWJ folding through the modifica-
tion of the FAM emission in light of the well-known FRET
relationship between the two fluorophores. It is worth not-
ing however that, even with this firmly established FRET-
pair, two fluorescence quenching mechanisms are possible,
the so called ‘FRET quenching’ and ‘contact quenching’:
these two mechanisms depend mainly on the distance be-
tween the donor and the acceptor, the FRET mode taking
place when within a 20–100 A˚ range, the contact mode oc-
curring when the two probes are brought closer (<20 A˚).
(66,67) These mechanisms both contribute to the global flu-
orescence modifications monitored during the TWJ-Screen
experiments to an extent that cannot be addressed read-
ily, as a result of the dynamic equilibria involved. The de-
veloped protocol allows for a selection of candidates in
(i) a practically convenient manner since it is neither tech-
nically demanding (mix-and-measure approach) nor time-
consuming (1 h at room temperature) and it can be ex-
panded to numerous other DNA and/or RNA sequences,
once the critical point of spontaneous, that is, non-ligand-
assisted TWJ folding is discarded; and (ii) a highly reliable
manner, as illustrated by the numerous controls (up to 5)
performed during each ligand evaluation that allow for the
detection of false negatives and positives (originating for
instance in unwanted interactions with FAM). This makes
TWJ-Screen assay virtually suited to any type of molecule,
provided itminimally absorbs light at FAMexcitationwave-
length (λex = 492nm). In its basic conformation (presented
here), TWJ-Screen still allows for assaying such molecules
thanks to the comparison of their interaction with FAM-
TWJ-S1 alone and the mixture FAM-TWJ-S1 + TWJ-S2
+ TWJ-S3-TAMRA; however, an astute selection of differ-
ent interactive fluorophore pairs (67) among themany com-
mercial possibilities might confirm these preliminary results
and address this critical issue straightforwardly.We thus be-
lieve that this HTS assay is robust and versatile enough to
be now ready to be used with wider chemical libraries. We
look forward to further assessing its effectiveness to identify
new chemical scaffolds that expand the portfolio of existing
DNAdamaging drugs, triggering genetic instability accord-
ing to an innovative mechanism of action, thus offering an
innovative and promising anticancer strategy.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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